Apellis Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 12.30 M | $269.07 M | 4.26% | 9.81% |
| AVORO CAPITAL ADVISORS LLC | 05/15/2025 | 12.22 M | $267.30 M | 0.00% | 9.74% |
| ECOR1 CAPITAL, LLC | 05/15/2025 | 11.90 M | $260.16 B | 0.04% | 9.48% |
| VANGUARD GROUP INC | 05/09/2025 | 10.13 M | $221.55 M | 0.84% | 8.08% |
| MORGAN STANLEY | 05/15/2025 | 9.63 M | $210.52 M | -0.01% | 7.67% |
| BLACKROCK, INC. | 05/02/2025 | 6.33 M | $138.43 M | -2.29% | 5.05% |
| DEEP TRACK CAPITAL, LP | 05/15/2025 | 5.00 M | $109.35 M | 16.96% | 3.99% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 4.08 M | $89.17 M | 119.64% | 3.25% |
| STATE STREET CORP | 05/15/2025 | 3.94 M | $86.20 M | -12.90% | 3.14% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 3.13 M | $68.48 M | 86.37% | 2.50% |
| SIREN, L.L.C. | 05/23/2025 | 2.58 M | $56.39 M | -8.45% | 2.06% |
| JENNISON ASSOCIATES LLC | 05/05/2025 | 2.48 M | $54.18 M | -10.25% | 1.97% |
| OCTAGON CAPITAL ADVISORS LP | 05/16/2025 | 2.09 M | $45.80 M | -30.36% | 1.67% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.95 M | $42.66 M | 6.04% | 1.55% |
| DEUTSCHE BANK AG\ | 05/09/2025 | 1.78 M | $38.85 M | -0.10% | 1.42% |
| BRAIDWELL LP | 05/15/2025 | 1.65 M | $36.14 M | -21.27% | 1.32% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 1.65 M | $36.01 M | 107.59% | 1.31% |
| POLAR CAPITAL HOLDINGS PLC | 05/15/2025 | 1.58 M | $34.49 M | 0.00% | 1.26% |
| FMR LLC | 05/12/2025 | 1.50 M | $32.88 M | -29.35% | 1.20% |
| ORBIMED ADVISORS LLC | 05/15/2025 | 1.43 M | $31.32 M | 100.00% | 1.14% |
| BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 1.11 M | $24.29 M | 30.55% | 0.89% |
| CANADA PENSION PLAN INVESTMENT BOARD | 05/15/2025 | 1.05 M | $22.94 M | 2,879.26% | 0.84% |
| MAN GROUP PLC | 05/15/2025 | 1.03 M | $22.48 M | 1,985.11% | 0.82% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 964.50 K | $21.09 M | -3.24% | 0.77% |
| ROYAL BANK OF CANADA | 05/15/2025 | 794.94 K | $17.38 M | -47.66% | 0.63% |
| NATIONAL BANK OF CANADA /FI/ | 05/12/2025 | 782.70 K | $17.12 M | -43.51% | 0.62% |
| 05/15/2025 | 713.00 K | $15.59 B | -50.00% | 0.57% | |
| NATIXIS | 05/14/2025 | 655.03 K | $14.78 M | -24.76% | 0.52% |
| INVESCO LTD. | 05/12/2025 | 641.40 K | $14.03 M | 6.25% | 0.51% |
| JEFFERIES FINANCIAL GROUP INC. | 05/08/2025 | 599.26 K | $13.11 M | 75.55% | 0.48% |
| NORTHERN TRUST CORP | 05/13/2025 | 518.69 K | $11.34 M | -5.22% | 0.41% |
| 05/12/2025 | 492.24 K | $10.77 M | 100.00% | 0.39% | |
| AMERIPRISE FINANCIAL INC | 05/14/2025 | 466.66 K | $10.21 M | -47.14% | 0.37% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 451.97 K | $9.88 M | -21.46% | 0.36% |
| SQUAREPOINT OPS LLC | 05/15/2025 | 442.79 K | $9.68 M | 165.21% | 0.35% |
| JPMORGAN CHASE & CO | 05/12/2025 | 423.80 K | $9.27 M | 2.98% | 0.34% |
| CITIGROUP INC | 05/12/2025 | 416.62 K | $9.11 M | 116.81% | 0.33% |
| TREXQUANT INVESTMENT LP | 05/14/2025 | 384.92 K | $8.42 M | 89.61% | 0.31% |
| SG AMERICAS SECURITIES, LLC | 04/15/2025 | 366.14 K | $8.01 M | 598.73% | 0.29% |
| ALGERT GLOBAL LLC | 05/13/2025 | 338.61 K | $7.41 M | 19.95% | 0.27% |
| 683 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 333.00 K | $7.28 M | -7.50% | 0.27% |
| AMUNDI | 05/15/2025 | 329.58 K | $7.42 M | 0.00% | 0.26% |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 329.17 K | $7.20 M | -1.57% | 0.26% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 324.49 K | $7.10 M | -56.40% | 0.26% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 323.50 K | $7.07 M | -62.35% | 0.26% |
| WALLEYE CAPITAL LLC | 05/14/2025 | 317.44 K | $6.94 M | -19.60% | 0.25% |
| PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 314.84 K | $7.62 M | -9.49% | 0.25% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 05/14/2025 | 310.70 K | $6.80 M | -9.94% | 0.25% |
| GOLDMAN SACHS GROUP INC | 05/16/2025 | 307.71 K | $6.73 M | 26.65% | 0.25% |
| IEQ CAPITAL, LLC | 05/14/2025 | 291.86 K | $6.38 M | 130.34% | 0.23% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Apellis Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 347 institutional investors and hedge funds held shares of Apellis Pharmaceuticals, Inc.. The most heavily invested institutionals were:
WELLINGTON MANAGEMENT GROUP LLP: 12.3 M
Avoro Capital Advisors LLC: 12.22 M
EcoR1 Capital, LLC: 11.9 M
VANGUARD GROUP INC: 10.13 M
MORGAN STANLEY: 9.63 M
BlackRock, Inc.: 6.33 M
100.79% of Apellis Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 134.93 M shares in the last 24 months. This purchase volume represents approximately $2.35 B in transactions.